Dietz, Beatrix and Zaby, Andreas. "8. Strategic Decisions under the EU Regulatory Framework for Orphan Drugs".
Healthcare: Market Dynamics, Policies and Strategies in Europe, edited by Mario Glowik and Slawomir Smyczek, Berlin, München, Boston: De Gruyter Oldenbourg, 2015, pp. 145-156.
https://doi.org/10.1515/9783110414844-009Dietz, B. & Zaby, A. (2015). 8. Strategic Decisions under the EU Regulatory Framework for Orphan Drugs. In M. Glowik & S. Smyczek (Ed.),
Healthcare: Market Dynamics, Policies and Strategies in Europe (pp. 145-156). Berlin, München, Boston: De Gruyter Oldenbourg.
https://doi.org/10.1515/9783110414844-009Dietz, B. and Zaby, A. 2015. 8. Strategic Decisions under the EU Regulatory Framework for Orphan Drugs. In: Glowik, M. and Smyczek, S. ed.
Healthcare: Market Dynamics, Policies and Strategies in Europe. Berlin, München, Boston: De Gruyter Oldenbourg, pp. 145-156.
https://doi.org/10.1515/9783110414844-009Dietz, Beatrix and Zaby, Andreas. "8. Strategic Decisions under the EU Regulatory Framework for Orphan Drugs" In
Healthcare: Market Dynamics, Policies and Strategies in Europe edited by Mario Glowik and Slawomir Smyczek, 145-156. Berlin, München, Boston: De Gruyter Oldenbourg, 2015.
https://doi.org/10.1515/9783110414844-009Dietz B, Zaby A. 8. Strategic Decisions under the EU Regulatory Framework for Orphan Drugs. In: Glowik M, Smyczek S (ed.)
Healthcare: Market Dynamics, Policies and Strategies in Europe. Berlin, München, Boston: De Gruyter Oldenbourg; 2015. p.145-156.
https://doi.org/10.1515/9783110414844-009Copied to clipboard
